<p>Characteristics including previous ALL treatment and hormone supplementation in 38 ALL survivors divided by gender with no significant difference in treatment modalities between gender.</p
Baseline characteristics of participants according to gender and presence of insulin resistance.</p
<p>Comparison of basic characteristics between cervical cancer survivors and female respondents neve...
<p>M, male; F, female.</p><p>Baseline characteristics of the enrolled patients.</p
<p>The individuals in all three groups had no significant difference in gender (X2 = 0.256, P = 0.88...
<p>Baseline characteristics of the 5135 female participants according to their use of hormone treatm...
<p>Baseline characteristics of women who never received any treatment with (n = 663) and without inc...
<p>Demographic and clinical characteristics of participants stratified by gender.</p
<p>Characteristics of cancer survivors aged 60 years or older from the NHANES (2011–2014), by gender...
<p>HRT: Hormone replacement therapy</p><p>*999 female and 768 male individuals with available measur...
<p>Data are shown as absolute (n) and relative (%) frequencies for categorical variables and as mean...
<p>Characteristics of subjects stratified by sex and the presence/absence of metabolic syndrome.</p
<p>Baseline characteristics of women who ever received antiosteoporotic treatment t with (n = 50) an...
<p>Socio-demographic and clinical characteristics of all participants and according to gender.</p
<p>Note: RT = survivors who received radiation treatment with or without chemotherapy, NRT = survivo...
*<p>p<0.0001 Data expressed as mean (SD), median (min-max), or percentages. PTH = parathormone, AP =...
Baseline characteristics of participants according to gender and presence of insulin resistance.</p
<p>Comparison of basic characteristics between cervical cancer survivors and female respondents neve...
<p>M, male; F, female.</p><p>Baseline characteristics of the enrolled patients.</p
<p>The individuals in all three groups had no significant difference in gender (X2 = 0.256, P = 0.88...
<p>Baseline characteristics of the 5135 female participants according to their use of hormone treatm...
<p>Baseline characteristics of women who never received any treatment with (n = 663) and without inc...
<p>Demographic and clinical characteristics of participants stratified by gender.</p
<p>Characteristics of cancer survivors aged 60 years or older from the NHANES (2011–2014), by gender...
<p>HRT: Hormone replacement therapy</p><p>*999 female and 768 male individuals with available measur...
<p>Data are shown as absolute (n) and relative (%) frequencies for categorical variables and as mean...
<p>Characteristics of subjects stratified by sex and the presence/absence of metabolic syndrome.</p
<p>Baseline characteristics of women who ever received antiosteoporotic treatment t with (n = 50) an...
<p>Socio-demographic and clinical characteristics of all participants and according to gender.</p
<p>Note: RT = survivors who received radiation treatment with or without chemotherapy, NRT = survivo...
*<p>p<0.0001 Data expressed as mean (SD), median (min-max), or percentages. PTH = parathormone, AP =...
Baseline characteristics of participants according to gender and presence of insulin resistance.</p
<p>Comparison of basic characteristics between cervical cancer survivors and female respondents neve...
<p>M, male; F, female.</p><p>Baseline characteristics of the enrolled patients.</p